"The Reddit discussion highlights the approval of Novo Nordisk's WegovyÂ® by the FDA for the treatment of MASH, indicating a positive sentiment towards the company's growth potential in the obesity treatment market. Key investment themes include the drug's anticipated impact on revenue and market share, alongside concerns regarding competition and regulatory developments in the pharmaceutical sector."